<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01304225</url>
  </required_header>
  <id_info>
    <org_study_id>PASCAL-001</org_study_id>
    <nct_id>NCT01304225</nct_id>
  </id_info>
  <brief_title>Panretinal Photocoagulation for Diabetic Retinopathy With PASCAL Laser</brief_title>
  <official_title>Panretinal Photocoagulation for Diabetic Retinopathy With PASCAL Laser - an Anatomic and Functional Evaluation of Different Treatment Strategies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federal University of S達o Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federal University of S達o Paulo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will investigate the clinical efficacy and safety of the PASCAL laser (PAttern
      SCAn Laser) for diabetic retinopathy. Patients with proliferative or severe nonproliferative
      retinopathy will be treated with panretinal photocoagulation utilizing different treatment
      strategies. The investigators believe that using &quot;lower&quot; laser parameters, the clinical
      response may be equivalent with less adverse effects.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2010</start_date>
  <completion_date type="Anticipated">March 2013</completion_date>
  <primary_completion_date type="Anticipated">March 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of severe visual loss after 1 year</measure>
    <time_frame>1 year</time_frame>
    <description>Severe visual loss is defined as visual acuity worse or equal to 5/200 in two consecutive visits (DRS/ETDRS primary outcome)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical involution of retinal new vessels</measure>
    <time_frame>1 year</time_frame>
    <description>Clinical involution of retinal new vessels will be evaluated with retinography and fluorescein angiography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nerve fiber layer thickness</measure>
    <time_frame>1 year</time_frame>
    <description>Nerve fiber layer thickness will be evaluated with Spectral Domain OCT</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Retinal sensitivity</measure>
    <time_frame>1 year</time_frame>
    <description>Retinal sensitivity will be evaluated with Humphrey computerized perimetry and FDT (Frequency Doubling Technology)</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Diabetic Retinopathy</condition>
  <arm_group>
    <arm_group_label>100ms single-shot</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Panretinal photocoagulation utilizing 100ms pulse duration, moderate intensity burns, in a single-shot fashion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>20ms multiple-shot</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Panretinal photocoagulation utilizing 20ms pulse duration, moderate intensity burns, in a multiple-shot fashion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>20ms multiple-shot, barely visible</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Panretinal photocoagulation utilizing 20ms pulse duration, barely visible intensity burns, in a multiple-shot fashion</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Panretinal photocoagulation</intervention_name>
    <description>Panretinal photocoagulation utilizing 100ms pulse duration, moderate intensity burns, in a single-shot fashion</description>
    <arm_group_label>100ms single-shot</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Panretinal photocoagulation</intervention_name>
    <description>Panretinal photocoagulation utilizing 20ms pulse duration, moderate intensity burns, in a multiple-shot fashion</description>
    <arm_group_label>20ms multiple-shot</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Panretinal photocoagulation</intervention_name>
    <description>Panretinal photocoagulation utilizing 20ms pulse duration, barely visible intensity burns, in a multiple-shot fashion</description>
    <arm_group_label>20ms multiple-shot, barely visible</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  proliferative or severe nonproliferative diabetic retinopathy (type 1 or type 2)

          -  best corrected visual acuity of 20/50 or better

          -  capability to read and follow instructions

          -  capability to sign the consignment term

        Exclusion Criteria:

          -  best corrected visual acuity worse than 20/50

          -  significant macular edema responsible for visual acuity lower than 20/50

          -  media opacities (includes vitreous hemorrhage in the visual axis, but not a
             reabsorbing inferior vitreous hemorrhage)

          -  previous laser treatment (PRP, focal or macular grid)

          -  glaucoma (confirmed or suspicious)

          -  other diseases of the retina and optic nerve

          -  previous ocular surgery in the last 6 months

          -  impossibility to obtain good quality images of retinography, angiography or OCT
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Renato M Passos, MD</last_name>
    <phone>55 11 50852043</phone>
    <email>renatompassos@yahoo.com.br</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Ophthalmology, Federal University of S達o Paulo</name>
      <address>
        <city>S達o Paulo</city>
        <state>SP</state>
        <zip>04023062</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <reference>
    <citation>Modi D, Chiranand P, Akduman L. Efficacy of patterned scan laser in treatment of macular edema and retinal neovascularization. Clin Ophthalmol. 2009;3:465-70. Epub 2009 Aug 20.</citation>
    <PMID>19714265</PMID>
  </reference>
  <reference>
    <citation>Muqit MM, Gray JC, Marcellino GR, Henson DB, Young LB, Patton N, Charles SJ, Turner GS, Dick AD, Stanga PE. In vivo laser-tissue interactions and healing responses from 20- vs 100-millisecond pulse Pascal photocoagulation burns. Arch Ophthalmol. 2010 Apr;128(4):448-55. doi: 10.1001/archophthalmol.2010.36.</citation>
    <PMID>20385940</PMID>
  </reference>
  <reference>
    <citation>Muqit MM, Marcellino GR, Henson DB, Young LB, Patton N, Charles SJ, Turner GS, Stanga PE. Single-session vs multiple-session pattern scanning laser panretinal photocoagulation in proliferative diabetic retinopathy: The Manchester Pascal Study. Arch Ophthalmol. 2010 May;128(5):525-33. doi: 10.1001/archophthalmol.2010.60.</citation>
    <PMID>20457972</PMID>
  </reference>
  <reference>
    <citation>Nagpal M, Marlecha S, Nagpal K. Comparison of laser photocoagulation for diabetic retinopathy using 532-nm standard laser versus multispot pattern scan laser. Retina. 2010 Mar;30(3):452-8. doi: 10.1097/IAE.0b013e3181c70127.</citation>
    <PMID>20216293</PMID>
  </reference>
  <verification_date>February 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 24, 2011</study_first_submitted>
  <study_first_submitted_qc>February 24, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 25, 2011</study_first_posted>
  <last_update_submitted>February 24, 2011</last_update_submitted>
  <last_update_submitted_qc>February 24, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 25, 2011</last_update_posted>
  <responsible_party>
    <name_title>Renato Magalh達es Passos</name_title>
    <organization>Doctor at the Ophthalmology Department of UNIFESP</organization>
  </responsible_party>
  <keyword>diabetic retinopathy</keyword>
  <keyword>photocoagulation</keyword>
  <keyword>PASCAL laser</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Retinal Diseases</mesh_term>
    <mesh_term>Diabetic Retinopathy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

